Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction

NeuroImage

Volumn 26, Issue 1, 2005, Pages 83-90

  Cyr, Michel ^a   Caron, Marc G ^a   Johnson, G Allan ^b   Laakso, Aki ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Basal ganglia; Brain morphology; Dopamine transporter; Mouse models; MRI; Neuropsychiatric disorders

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CORPUS STRIATUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPAMINERGIC HYPERFUNCTION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; MALE; MOUSE; NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEREOMETRY; SUBSTANTIA NIGRA; WILD TYPE;

EID: 18044373435     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2005.01.039     Document Type: Article

References (31)

1. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L.S. Kegeles, R. Weiss, T.B. Cooper, J.J. Mann, R.L. Van Heertum, J.M. Gorman, and M. Laruelle Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc. Natl. Acad. Sci. U. S. A. 97 2000 8104 8109
2. H. Benveniste, K. Kim, L. Zhang, and G.A. Johnson Magnetic resonance microscopy of the C57BL mouse brain NeuroImage 11 2000 601 611
3. A. Carlsson, N. Waters, S. Waters, and M.L. Carlsson Network interactions in schizophrenia-therapeutic implications Brain Res. Brain Res. Rev. 31 2000 342 349
4. F.X. Castellanos, and R. Tannock Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes Nat. Rev., Neurosci. 3 2002 617 628
5. M. Cyr, J.M. Beaulieu, A. Laakso, T.D. Sotnikova, W.D. Yao, L.M. Bohn, R.R. Gainetdinov, and M.G. Caron Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons Proc. Natl. Acad. Sci. U. S. A. 100 2003 11035 11040
6. P.O. Fernagut, E. Diguet, M. Jaber, B. Bioulac, and F. Tison Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage Eur. J. Neurosci. 15 2002 2053 2056
7. P.O. Fernagut, S. Chalon, E. Diguet, D. Guilloteau, F. Tison, and M. Jaber Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice Neuroscience 116 2003 1123 1130
8. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
9. R.R. Gainetdinov, A.R. Mohn, and M.G. Caron Genetic animal models: focus on schizophrenia Trends Neurosci. 24 2001 527 533
10. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
11. N. Gogtay, J. Giedd, and J.L. Rapoport Brain development in healthy, hyperactive, and psychotic children Arch. Neurol. 59 2002 1244 1248
12. R.E. Gur, V. Maany, P.D. Mozley, C. Swanson, W. Bilker, and R.C. Gur Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia Am. J. Psychiatry 155 1998 1711 1717
13. J. Hietala, E. Syvalahti, K. Vuorio, V. Rakkolainen, J. Bergman, M. Haaparanta, O. Solin, M. Kuoppamaki, O. Kirvela, and U. Ruotsalainen Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients Lancet 346 1995 1130 1131
14. M. Jaber, B. Dumartin, C. Sagne, J.W. Haycock, C. Roubert, B. Giros, B. Bloch, and M.G. Caron Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter Eur. J. Neurosci. 11 1999 3499 3511
15. G.A. Johnson, H. Benveniste, R.D. Black, L.W. Hedlund, R.R. Maronpot, and B.R. Smith Histology by magnetic resonance microscopy Magn. Reson. Q. 9 1993 1 30
16. G.A. Johnson, G.P. Cofer, B. Fubara, S.L. Gewalt, L.W. Hedlund, and R.R. Maronpot Magnetic resonance histology for structural phenotyping J. Magn. Reson. Imaging 16 2002 423 429
17. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc. Natl. Acad. Sci. U. S. A. 95 1998 4029 4034
18. M.S. Keshavan, D. Rosenberg, J.A. Sweeney, and J.W. Pettegrew Decreased caudate volume in neuroleptic-naive psychotic patients Am. J. Psychiatry 155 1998 774 778
19. D.E. Oorschot The total number of neurons in the neostriatum, pallidal, subthalamic and substantia nigral nuclei of the rat basal ganglia: a stereological study using the Cavalieri and optical disector method J. Comp. Neurol. 366 1996 580 599
20. B. Pakkenberg, and H.J. Gundersen Neocortical neuron number in humans: effect of sex and age J. Comp. Neurol. 384 1997 312 320
21. G. Paxinos, and K.J. Franklin The mouse brain in stereotaxic coordinates 2001 Academic San Diego
22. B.S. Peterson, P. Thomas, M.J. Kane, L. Scahill, H. Zhang, R. Bronen, R.A. King, J.F. Leckman, and L. Staib Basal ganglia volumes in patients with Gilles de la Tourette syndrome Arch. Gen. Psychiatry 60 2003 415 424
23. M.L. Phillips, W.C. Drevets, S.L. Rauch, and R. Lane Neurobiology of emotion perception II: implications for major psychiatric disorders Biol. Psychiatry 54 2003 515 528
24. J.M. Redwine, B. Kosofsky, R.E. Jacobs, D. Games, J.F. Reilly, J.H. Morrison, W.G. Young, and F.E. Bloom Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis Proc. Natl. Acad. Sci. U. S. A. 100 2003 1381 1386
25. M.M. Robertson, and J.S. Stern The Gilles de la Tourette syndrome Crit. Rev. Neurobiol. 11 1997 1 19
26. M.E. Shenton, C.C. Dickey, M. Frumin, and R.W. McCarley A review of MRI findings in schizophrenia Schizophr. Res. 49 2001 1 52
27. C. Sotelo Anatomical, physiological and biochemical studies of the cerebellum from mutant mice: II. Morphological study of cerebellar cortical neurons and circuits in the weaver mouse Brain Res. 94 1975 19 44
28. J.M. Swanson, and N.D. Volkow Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD Behav. Brain Res. 130 2002 73 78
29. C.A. Tamminga, and A. Carlsson Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr. Drug Targets. CNS Neurol. Disord. 1 2002 141 147
30. D.R. Weinberger, and R.K. McClure Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch. Gen. Psychiatry 59 2002 553 558
31. W.D. Yao, R.R. Gainetdinov, M.I. Arbuckle, T.D. Sotnikova, M. Cyr, J.M. Beaulieu, G.E. Torres, S.G. Grant, and M.G. Caron Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity Neuron 41 2004 625 638